Ann: Cancellation of Performance Options, page-4

That should be explained in the annual report if you want to go have a read. I really want Alison Coutts to do well out of this venture, along with the other shareholders, given how much personal skin she has put into it.

Keep going Alison, and please drop us an update. I assume we get a half yearly report next week. I am looking forward to a progress update on the previous update which stated:

Preliminary sales discussions have commenced with some early market KOL partners; however they haverequested to conduct further Felix testing with production devices from the initial production run and with the new optimised operating protocols, to ensure consistency with earlier results, before resuming commercial discussions. These devices and cartridges have been sent to these KOL partners, with optimised assessment to occur using these devices in January/ February 2021.Given the adverse current impact of Covid-19 including shutdown of many of our KOL clinics, and the KOLS in early markets seeking to undertake testing of new optimised protocols for their practices using production devices), the Company now anticipates first KOL commercial sales in ‘early markets’ to occur in Mar/Apr 2021.